课题基金 / 基金详情

Postdoctoral Research Training in Biotherapy of Cancer

Postdoctoral Research Training in Biotherapy of Cancer
癌症生物治疗博士后研究培训
批准号:
7493643
负责人:
DAVID L BARTLETT
金额:
$15.61万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-08-01 至 2011-06-30

项目摘要

项目成果

DAVID L BARTLETT的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):这个博士后培训计划是一个培训外科住院医生和研究员在基础科学研究相关的肿瘤学和癌症的生物治疗的建议。在过去的几十年里,细胞生物学、肿瘤免疫学和人类遗传学的进步已经允许开发出治疗癌症的第一种有效的生物疗法。匹兹堡大学癌症研究所(UPCI)和外科肿瘤学部门在这些领域做出了重大承诺,开展了广泛的临床前和临床研究计划。希尔曼癌症中心最近增加了UPCI研究馆和库珀癌症馆,进一步表明了基础和临床学科之间广泛整合的承诺。因此,培训一批高素质的个人,他们可以担任学术外科医生的领导角色,并推动基础研究转化为临床癌症治疗,这是外科肿瘤学部门的一项明确的使命,也是本计划提案的最终目标。癌症生物治疗的五个主要研究领域可供学员使用:1)免疫治疗,2)细胞因子治疗,3)基因治疗,4)靶向分子治疗,5)基因组学和蛋白质组学。每个学员将参与为期两年的强化指导实验室研究,其中一名来自这五个重点学科之一的已建立和资助的实验室科学家。学员和导师将每周一次一对一的会面。除了密集的实验室经验,实习生还将参加一些正式的课程,研讨会计划和期刊俱乐部。学员的进步以及导师的活动由一个行政委员会监督和评估。在培训期结束时,学员将获得必要的技能,成熟为独立的研究者,以弥合差距,并推动基础研究转化为临床终点。
英文摘要
DESCRIPTION (provided by applicant): This postdoctoral training program is a proposal for training surgical residents and fellows in basic science research relevant to oncology and the biological therapy of cancer. Over the past few decades, advances in cell biology, tumor immunology and human genetics have permitted the development of the first efficacious biotherapies in the treatment of cancer. The University of Pittsburgh Cancer Institute (UPCI) and the Division of Surgical Oncology have made a major commitment in these areas with extensive preclinical and clinical research programs. The recent addition of the Hillman Cancer Center housing both the UPCI Research Pavilion and the Cooper Cancer Pavilion further demonstrates the commitment for a broad integration between the basic and clinical disciplines. As such, the training of a diverse group of highly qualified individuals who can assume leadership roles as academic surgeons and drive the translation of basic research into clinical cancer therapy is an identified mission of the Division of Surgical Oncology and the ultimate goal of this program proposal. Five major areas of research focus within cancer biotherapy are available for the trainees: 1) Immunotherapy, 2) Cytokine Therapy, 3) Gene Therapy, 4) Targeted Molecular Therapy, and 5) Genomics and Proteomics. Each trainee will be involved in intensive mentored laboratory research for two years with an established and funded laboratory scientist from one of these five focused disciplines. The trainee and the preceptor will meet one-on-one on a weekly basis. In addition to the intensive laboratory experience, the trainee will also participate in a number of formal courses, seminar programs, and journal clubs. The trainee's progress, as well as, the preceptor's activities are monitored and evaluated by an Administrative Committee. At the conclusion of the training period, the trainees will have gained skills necessary for the maturation into independent investigators to bridge the gap and drive the translation of basic research into clinical endpoints.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tumor-Selective Oncolytic Vaccinia Virus and alphaDC1-Based Vaccine as a Combinat
Improving Vaccinia for Peritoneal Tumors: Enhanced Distribution & Immune Evasion
Improving Vaccinia for Peritoneal Tumors: Enhanced Distribution & Immune Evasion
Improving Vaccinia for Peritoneal Tumors: Enhanced Distribution & Immune Evasion
海外基金